Author

G. Wainwright

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

A. Hanker· 1 shared A. Mukherji· 1 shared C. Arteaga· 1 shared C. Rodriguez· 1 shared C. Wang· 1 shared F. Feng· 1 shared G. Raj· 1 shared H. He· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Hanker

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ZNF397 Loss Triggers TET2-driven Epigenetic Rewiring, Lineage Plasticity, and AR-targeted Therapy Resistance in AR-dependent Cancers

P. Mu, Y. Xu, Z. Wang, M. Sjostrom, S. Deng, C. Wang, N. Jonhson, J. Gonzalez, X. Li, L. Metang, C. Rodriguez, A. Mukherji, G. Wainwright, X. Yu, Y. Yang, , T. Wang

This study shows ZNF397 loss leads to TET2-driven epigenetic changes, lineage plasticity, and resistance to AR-targeted therapies in AR-dependent cancers, with TET2 inhibitors reversing resistance.

bioRxiv · Oct 24, 2023Cancer Biology